XPLENDED

This brand name is authorized in Nigeria.

Active ingredients

The drug XPLENDED contains one active pharmaceutical ingredient (API):

1	Rosuvastatin UNII 83MVU38M7Q - ROSUVASTATIN CALCIUM
	Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase. Rosuvastatin increases the number of hepatic LDL receptors on the cell-surface, enhancing uptake and catabolism of LDL and it inhibits the hepatic synthesis of VLDL, thereby reducing the total number of VLDL and LDL particles.
	Read more about Rosuvastatin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9122	Tablet	Xplended Tablets 5 mg TAB 5 mg 3 X 10	50 RNW-PP-362721 Xplended Tablets 5mg ROSUVASTATIN 5mg 5.2 mg rosuvastatin (as rosuvastatin calcium),M.C. Cellulose PH -102 Tablettose 80 H.P.M.C Pharmacoat 606 (2910) Iron Oxide Yellow Crospovidone Colloidal Silicon Dioxide (Aerosil 200) Magnesium Stearate Sodium Dodecyl Sulphate Opadry White ii 85G68918 Purified Water B4-9122 Drugs Imported Products 310 Prescription Only Medicine (POM) 10/13/2023 FENSYL MHP CONSULTING LIMITED, NO. 49, KOFO ABAYOMI STREET, APAPA NULL NULL, LAGOS 8033221004 fensylmhpconsultingltd@gmail.com PharmEvo (PVT) Limited, Plot No. A-29, North Western Industrial Zone, Port Qasim, Karachi-75020, Pakistan. , Pakistan	25/09/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AA07	Rosuvastatin	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9121, B4-9122